2021
DOI: 10.1016/j.heares.2020.108093
|View full text |Cite
|
Sign up to set email alerts
|

Translational implications of the interactions between hormones and age-related hearing loss

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 77 publications
0
8
0
Order By: Relevance
“…Therefore, aside from using systemic estrogen as a therapy, localized use may be the better choice to apply estrogen and its derivatives to improve hearing impairment. Some strategies for cochlear drug delivery such as nanoparticles, hydrogels, or micropumps can be the focus of future investigations [ 143 , 144 ].…”
Section: The Effect Of Hormone Therapy On Hearingmentioning
confidence: 99%
“…Therefore, aside from using systemic estrogen as a therapy, localized use may be the better choice to apply estrogen and its derivatives to improve hearing impairment. Some strategies for cochlear drug delivery such as nanoparticles, hydrogels, or micropumps can be the focus of future investigations [ 143 , 144 ].…”
Section: The Effect Of Hormone Therapy On Hearingmentioning
confidence: 99%
“…In women, muscle strength starts declining during early postmenopausal ages, earlier than in men [34]. Moreover, testosterone has been reported to have a negative effect on hearing [35]. The diminishing levels of testosterone in the elderly males may help their hearing, compared to the aged females, while muscle strength declines by aging.…”
Section: Plos Onementioning
confidence: 99%
“…Given its critical involvement in aging changes in cochlear function, NKCC1 could be a potential therapeutic target for new ARHL treatments. Provocatively, the chronic treatment of aging CBA/CaJ mice with aldosterone, a natural occurring hormone that declines with age in mammals, prevents certain key aspects of ARHL (relative to aging control mice); i.e., aldosterone hormone therapy improved auditory brainstem response thresholds and improved survival of spiral ganglion neurons via inhibition of age-related downregulation of NKCC1 and apoptotic pathways [ 46 , 47 , 48 , 62 ].…”
Section: Sodium-potassium-chloride Cotransportermentioning
confidence: 99%